The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in newly diagnosed diffuse large B cell lymphoma presenting with hepatic and/ or renal dysfunction.
 
Srinivasa Reddy Sanikommu
No Relationships to Disclose
 
Hu Bei
No Relationships to Disclose
 
Myra M. Robinson
No Relationships to Disclose
 
Jigar S. Trivedi
Consulting or Advisory Role - Pharmacyclics
 
Taylor Brown
No Relationships to Disclose
 
Steven I. Park
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Rafa Pharmaceutical; Teva
Speakers' Bureau - Gilead Sciences; Seagen
Research Funding - Bristol-Myers Squibb; Seagen; Takeda; Teva
 
Ryan Jacobs
Stock and Other Ownership Interests - TG Therapeutics
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences; Juno Therapeutics; Spectrum Pharmaceuticals
Speakers' Bureau - Genentech; Pharmacyclics
Research Funding - Pharmacyclics; TG Therapeutics
 
Avalos Belinda
Consulting or Advisory Role - Juno Therapeutics
 
Edward Alan Copelan
No Relationships to Disclose
 
Nilanjan Ghosh
Consulting or Advisory Role - Janssen; Juno Therapeutics; Kite, a Gilead company; Spectrum Pharmaceuticals
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen Oncology
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)